NCT06935513

Brief Summary

The purpose of this study is to evaluate the control effect of smart wearable devices on key risk factors in the high-risk populations for stroke

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P50-P75 for not_applicable hypertension

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable hypertension

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 30, 2025

Completed
21 days until next milestone

First Posted

Study publicly available on registry

April 20, 2025

Completed
Same day until next milestone

Study Start

First participant enrolled

April 20, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 20, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 20, 2026

Completed
Last Updated

April 30, 2025

Status Verified

March 1, 2025

Enrollment Period

6 months

First QC Date

March 30, 2025

Last Update Submit

April 27, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • medication adherence and risk factor control rates

    1.The medication rates and control rates for hypertension; 2.The medication rates and control rates for hyperglycemia; 3. The medication rates and control rates for hyperlipidemia; 4.The medication rates and control rates for obesity.

    6 months

Secondary Outcomes (1)

  • incident vascular events, including stroke, coronary heart disease (CHD), peripheral vascular disease (PVD), and other related cardiovascular events

    6 months

Study Arms (2)

With Wearable Devices

EXPERIMENTAL

Participants utilize wearable devices (smart wristbands) 24 hours a day for 6 months and receive medication reminders for each use and heart rate monitoring.

Behavioral: Wearable Devices

Without Wearable Devices

NO INTERVENTION

Participants do not utilize wearable devices (smart wristbands) .

Interventions

Participants utilize wearable devices (smart wristbands) 24 hours a day for 6 months. Wearable devices can provide medication reminders for each use and heart rate monitoring.

With Wearable Devices

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosed with hypertension;
  • Diagnosed with diabetes;
  • Diagnosed with atrial fibrillation;
  • Smoking subjects;
  • Physical inactive subjects;
  • Obesity and overweight subjects;
  • Must be able to use smart wearable devices.

You may not qualify if:

  • Diagnosed with malignancies;
  • Diagnosed with psychiatric disorders;
  • Diagnosed with cognitive impairment;
  • Unable to operate smart wearable devices.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Affiliated Hospital of Nantong University

Nantong, Jiangsu, 226000, China

RECRUITING

MeSH Terms

Conditions

HypertensionDiabetes MellitusAtrial FibrillationDyslipidemiasSmokingSedentary BehaviorObesityOverweight

Interventions

Wearable Electronic Devices

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular DiseasesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesArrhythmias, CardiacHeart DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsLipid Metabolism DisordersBehaviorOvernutritionNutrition DisordersBody WeightSigns and Symptoms

Intervention Hierarchy (Ancestors)

Electrical Equipment and SuppliesEquipment and Supplies

Study Officials

  • Qiuhong Ji, MD, PhD

    Affiliated Hospital of Nantong University

    STUDY CHAIR

Central Study Contacts

Qiuhong Ji, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 30, 2025

First Posted

April 20, 2025

Study Start

April 20, 2025

Primary Completion

October 20, 2025

Study Completion

April 20, 2026

Last Updated

April 30, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations